Companies: 49,247 Total Market Cap: 132662034420944.34

Celemics

KOSDAQ-331920
Surgical and Medical Instruments and Apparatus
Rank #36516
Market Cap 17.60 M
Volume 9,563
Price 2.13
Change (%) 1.65%
Country or region South Korea South Korea

Celemics's latest marketcap:

17.60 M

As of 05/21/2025, Celemics's market capitalization has reached $17.60 M. According to our data, Celemics is the 36516th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 17.60 M
Revenue (ttm) 4.81 M
Net Income (ttm) 8.78 M
Shares Out 8.16 M
EPS (ttm) 1.07
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/14/2025
Market Cap Chart
Data Updated: 05/21/2025

Celemics's yearly market capitalization.

Celemics has seen its market value drop from ₩216.33 B to ₩24.57 B since 2020, representing a total decrease of 88.64% and an annual compound decline rate (CAGR) of 39.08%.
Date Market Cap Change (%)
05/21/2025 ₩24.57 B -9.16%
12/30/2024 ₩26.74 B -22.58%
12/28/2023 ₩34.53 B -27.07%
12/29/2022 ₩47.35 B -62.21%
12/30/2021 ₩125.32 B -42.07%
12/30/2020 ₩216.33 B

Company Profile

About Celemics, Inc.

Celemics, Inc. is a biotechnology company specializing in the design, manufacture, and distribution of sequencing kits. Headquartered in Seoul, South Korea, the company was established in 2010 and serves a variety of research and clinical applications.

Products

  • Whole Exome Sequencing Panels – Comprehensive genomic analysis tools.
  • NGS Target Enrichment Panels – Customized and ready-to-use panels for precise sequencing.
  • Modular Accessories – Includes:
    • Library preparation kits
    • Double standard cDNA synthesis
    • Hybridization enhancer
    • Clean-up and streptavidin beads
    • CeleNM beads
    • Polymerase

Services

  • CeleMics Analysis
  • Whole Exome Sequencing
  • Customized NGS Panels
  • Sequencing & Bioinformatics
  • Biopharma Solutions
  • Custom NGS Assay Development

Applications

Celemics' products and services are utilized across diverse fields, including:

  • Oncology & Liquid Biopsy
  • Inherited Diseases & Pharmacogenomics
  • Virus Research & Agrigenomics
  • RNA Sequencing & Epigenetics
  • Metagenomic Sequencing
  • Antibody Discovery & Bioinformatics

The company continues to innovate in genomic research, providing advanced solutions for scientific and medical advancements.

Frequently Asked Questions

As of 05/21/2025, Celemics (including the parent company, if applicable) has an estimated market capitalization of $17.60 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Celemics global market capitalization ranking is approximately 36516 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 2010
IPO Date n/a
Employees n/a
CEO
Sector
Industry Surgical and Medical Instruments and Apparatus
Address Building A
Seoul, 08506
South Korea
Website https://www.celemics.com
People Also Watch
Ambu A/S
139.11 1.65%
CLASSYS
42.39 1.65%
KOSDAQ-336570
6.76 1.65%
VIOL
6.92 1.65%